Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease

HALT PKD and CRISP Investigators

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) often results in ESRD but with a highly variable course. Mutations to PKD1 or PKD2 cause ADPKD; both loci have high levels of allelic heterogeneity. We evaluated genotype-phenotype correlations in 1119 patients (945 families) from the HALT Progression of PKD Study and the Consortium of Radiologic Imaging Study of PKD Study. The population was defined as: 77.7% PKD1, 14.7% PKD2, and 7.6% with no mutation detected (NMD). Phenotypic end points were sex, eGFR, height-adjusted total kidney volume (htTKV), and liver cyst volume. Analysis of the eGFR and htTKV measures showed that the PKD1 group had more severe disease than the PKD2 group, whereas the NMD group had a PKD2-like phenotype. In both the PKD1 and PKD2 populations, men had more severe renal disease, but women had larger liver cyst volumes. Compared with nontruncating PKD1 mutations, truncating PKD1 mutations associated with lower eGFR, but the mutation groups were not differentiated by htTKV. PKD1 nontruncating mutations were evaluated for conservation and chemical change and subdivided into strong (mutation strength group 2 [MSG2]) and weak (MSG3) mutation groups. Analysis of eGFR and htTKV measures showed that patients with MSG3 but not MSG2 mutations had significantly milder disease than patients with truncating cases (MSG1), an association especially evident in extreme decile populations. Overall, we have quantified the contribution of genic and PKD1 allelic effects and sex to the ADPKD phenotype. Intrafamilial correlation analysis showed that other factors shared by families influence htTKV, with these additional genetic/environmental factors significantly affecting the ADPKD phenotype.

Original languageEnglish (US)
Pages (from-to)2872-2884
Number of pages13
JournalJournal of the American Society of Nephrology : JASN
Volume27
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Autosomal Dominant Polycystic Kidney
Genetic Association Studies
Mutation
Kidney
Phenotype
Cysts
Population
Liver
Chronic Kidney Failure

Keywords

  • ADPKD
  • Genotype/phenotype
  • Prognostic studies

ASJC Scopus subject areas

  • Nephrology

Cite this

Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease. / HALT PKD and CRISP Investigators.

In: Journal of the American Society of Nephrology : JASN, Vol. 27, No. 9, 01.09.2016, p. 2872-2884.

Research output: Contribution to journalArticle

@article{8e90a64b2da14faa8ab22dde2316f078,
title = "Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease",
abstract = "Autosomal dominant polycystic kidney disease (ADPKD) often results in ESRD but with a highly variable course. Mutations to PKD1 or PKD2 cause ADPKD; both loci have high levels of allelic heterogeneity. We evaluated genotype-phenotype correlations in 1119 patients (945 families) from the HALT Progression of PKD Study and the Consortium of Radiologic Imaging Study of PKD Study. The population was defined as: 77.7{\%} PKD1, 14.7{\%} PKD2, and 7.6{\%} with no mutation detected (NMD). Phenotypic end points were sex, eGFR, height-adjusted total kidney volume (htTKV), and liver cyst volume. Analysis of the eGFR and htTKV measures showed that the PKD1 group had more severe disease than the PKD2 group, whereas the NMD group had a PKD2-like phenotype. In both the PKD1 and PKD2 populations, men had more severe renal disease, but women had larger liver cyst volumes. Compared with nontruncating PKD1 mutations, truncating PKD1 mutations associated with lower eGFR, but the mutation groups were not differentiated by htTKV. PKD1 nontruncating mutations were evaluated for conservation and chemical change and subdivided into strong (mutation strength group 2 [MSG2]) and weak (MSG3) mutation groups. Analysis of eGFR and htTKV measures showed that patients with MSG3 but not MSG2 mutations had significantly milder disease than patients with truncating cases (MSG1), an association especially evident in extreme decile populations. Overall, we have quantified the contribution of genic and PKD1 allelic effects and sex to the ADPKD phenotype. Intrafamilial correlation analysis showed that other factors shared by families influence htTKV, with these additional genetic/environmental factors significantly affecting the ADPKD phenotype.",
keywords = "ADPKD, Genotype/phenotype, Prognostic studies",
author = "{HALT PKD and CRISP Investigators} and Heyer, {Christina M.} and Sundsbak, {Jamie L.} and Abebe, {Kaleab Z.} and Chapman, {Arlene B.} and Vicente Torres and Grantham, {Jared J.} and Bae, {Kyongtae T.} and Schrier, {Robert W.} and Perrone, {Ronald D.} and Braun, {William E.} and Steinman, {Theodore I.} and Michal Mrug and Yu, {Alan S.L.} and Godela Brosnahan and Katharina Hopp and {Irazabal Mira}, Maria and Bennett, {William M.} and Flessner, {Michael F.} and Moore, {Charity G.} and Douglas Landsittel and Harris, {Peter C}",
year = "2016",
month = "9",
day = "1",
doi = "10.1681/ASN.2015050583",
language = "English (US)",
volume = "27",
pages = "2872--2884",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "9",

}

TY - JOUR

T1 - Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease

AU - HALT PKD and CRISP Investigators

AU - Heyer, Christina M.

AU - Sundsbak, Jamie L.

AU - Abebe, Kaleab Z.

AU - Chapman, Arlene B.

AU - Torres, Vicente

AU - Grantham, Jared J.

AU - Bae, Kyongtae T.

AU - Schrier, Robert W.

AU - Perrone, Ronald D.

AU - Braun, William E.

AU - Steinman, Theodore I.

AU - Mrug, Michal

AU - Yu, Alan S.L.

AU - Brosnahan, Godela

AU - Hopp, Katharina

AU - Irazabal Mira, Maria

AU - Bennett, William M.

AU - Flessner, Michael F.

AU - Moore, Charity G.

AU - Landsittel, Douglas

AU - Harris, Peter C

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Autosomal dominant polycystic kidney disease (ADPKD) often results in ESRD but with a highly variable course. Mutations to PKD1 or PKD2 cause ADPKD; both loci have high levels of allelic heterogeneity. We evaluated genotype-phenotype correlations in 1119 patients (945 families) from the HALT Progression of PKD Study and the Consortium of Radiologic Imaging Study of PKD Study. The population was defined as: 77.7% PKD1, 14.7% PKD2, and 7.6% with no mutation detected (NMD). Phenotypic end points were sex, eGFR, height-adjusted total kidney volume (htTKV), and liver cyst volume. Analysis of the eGFR and htTKV measures showed that the PKD1 group had more severe disease than the PKD2 group, whereas the NMD group had a PKD2-like phenotype. In both the PKD1 and PKD2 populations, men had more severe renal disease, but women had larger liver cyst volumes. Compared with nontruncating PKD1 mutations, truncating PKD1 mutations associated with lower eGFR, but the mutation groups were not differentiated by htTKV. PKD1 nontruncating mutations were evaluated for conservation and chemical change and subdivided into strong (mutation strength group 2 [MSG2]) and weak (MSG3) mutation groups. Analysis of eGFR and htTKV measures showed that patients with MSG3 but not MSG2 mutations had significantly milder disease than patients with truncating cases (MSG1), an association especially evident in extreme decile populations. Overall, we have quantified the contribution of genic and PKD1 allelic effects and sex to the ADPKD phenotype. Intrafamilial correlation analysis showed that other factors shared by families influence htTKV, with these additional genetic/environmental factors significantly affecting the ADPKD phenotype.

AB - Autosomal dominant polycystic kidney disease (ADPKD) often results in ESRD but with a highly variable course. Mutations to PKD1 or PKD2 cause ADPKD; both loci have high levels of allelic heterogeneity. We evaluated genotype-phenotype correlations in 1119 patients (945 families) from the HALT Progression of PKD Study and the Consortium of Radiologic Imaging Study of PKD Study. The population was defined as: 77.7% PKD1, 14.7% PKD2, and 7.6% with no mutation detected (NMD). Phenotypic end points were sex, eGFR, height-adjusted total kidney volume (htTKV), and liver cyst volume. Analysis of the eGFR and htTKV measures showed that the PKD1 group had more severe disease than the PKD2 group, whereas the NMD group had a PKD2-like phenotype. In both the PKD1 and PKD2 populations, men had more severe renal disease, but women had larger liver cyst volumes. Compared with nontruncating PKD1 mutations, truncating PKD1 mutations associated with lower eGFR, but the mutation groups were not differentiated by htTKV. PKD1 nontruncating mutations were evaluated for conservation and chemical change and subdivided into strong (mutation strength group 2 [MSG2]) and weak (MSG3) mutation groups. Analysis of eGFR and htTKV measures showed that patients with MSG3 but not MSG2 mutations had significantly milder disease than patients with truncating cases (MSG1), an association especially evident in extreme decile populations. Overall, we have quantified the contribution of genic and PKD1 allelic effects and sex to the ADPKD phenotype. Intrafamilial correlation analysis showed that other factors shared by families influence htTKV, with these additional genetic/environmental factors significantly affecting the ADPKD phenotype.

KW - ADPKD

KW - Genotype/phenotype

KW - Prognostic studies

UR - http://www.scopus.com/inward/record.url?scp=84981157778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981157778&partnerID=8YFLogxK

U2 - 10.1681/ASN.2015050583

DO - 10.1681/ASN.2015050583

M3 - Article

C2 - 26823553

AN - SCOPUS:84981157778

VL - 27

SP - 2872

EP - 2884

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 9

ER -